News | tctmd.com

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Contingency plans are needed to curb mortality rates from conditions untreated during the next wave of the pandemic.

By Shelley Wood

October 22, 2020

As Cardiac Procedures Plummet, Concerns Mount for COVID-19’s Collateral Damage

Robotic PCI Can Protect Cath Lab Staff From COVID-19, Small Study Suggests

It remains unclear, however, whether the risk is all that high in the first place when adequate PPE is used.

By Todd Neale

October 22, 2020

Robotic PCI Can Protect Cath Lab Staff From COVID-19, Small Study Suggests

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Bare-metal stent performance was unexpectedly good, but this doesn’t mean they should stage a comeback, one expert stressed.

By L.A. McKeown

October 22, 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

COVID-19: TCTMD’s Daily Dispatch for October 22

Vaccine trial death, FDA advisory committee meets on vaccines, negative tocilizumab RCT, CDC redefines close contact, and more.

By Todd Neale

October 22, 2020

COVID-19: TCTMD’s Daily Dispatch for October 22

TCTMD Talking Points

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Even in expert centers, the rate of death at 1 year was close to 30%, with a 10% risk of stroke, international numbers show.

By L.A. McKeown

October 21, 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

FFRCT did reduce the use of invasive angiography, but the savings weren’t enough to offset the up-front costs of testing.

By Michael O'Riordan

October 21, 2020

No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

The findings largely mirrored what was seen in the overall trial, in terms of both efficacy and safety.

By Todd Neale

October 21, 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

More Than Half of All HF Patients Take 10 or More Meds

Medication needs in elderly HF patients should focus on self-identified health priorities, experts contend.

By L.A. McKeown

October 20, 2020

More Than Half of All HF Patients Take 10 or More Meds

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Attention is turning to symptom relief and how best to align treatment with the patient’s goals and preferences.

By Michael O'Riordan

October 19, 2020

Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

A phase III trial is in the planning stages, possibly combining the antiproliferative drug with dexamethasone, a steroid.

By Caitlin E. Cox

October 18, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study